ACMAT Corporation
ACMTA
$33.50
$0.000.00%
| Weiss Ratings | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.13 | |||
| Price History | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 1.24% | |||
| 60-Day Total Return | 1.52% | |||
| 90-Day Total Return | 1.52% | |||
| Year to Date Total Return | 1.52% | |||
| 1-Year Total Return | -4.29% | |||
| 2-Year Total Return | 9.84% | |||
| 3-Year Total Return | 3.72% | |||
| 5-Year Total Return | 63.41% | |||
| 52-Week High % Change | -4.29% | |||
| 52-Week Low % Change | 4.65% | |||
| Price | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $35.00 | |||
| 52-Week Low Price | $32.01 | |||
| 52-Week Low Price (Date) | Oct 10, 2022 | |||
| 52-Week High Price (Date) | Apr 05, 2022 | |||
| Valuation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $25.85M | |||
| Enterprise Value | 23.80M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.80 | |||
| Earnings Per Share Growth | -256.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 30.17 | |||
| Price/Book (Q) | 0.95 | |||
| Enterprise Value/Revenue (TTM) | 57.66 | |||
| Price | $33.50 | |||
| Enterprise Value/EBITDA (TTM) | -12.66 | |||
| Enterprise Value/EBIT | -11.35 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 771.500K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 860 415 8400 | |||
| Address | 30 South Road Farmington, CT 06032-2418 | |||
| Website | www.acmatcorp.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -508.09% | |||
| Profit Margin | -458.66% | |||
| Management Effectiveness | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.39% | |||
| Return on Equity | -- | |||
| Income Statement | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $2.54M | |||
| Total Revenue (TTM) | $412.70K | |||
| Revenue Per Share | $0.54 | |||
| Gross Profit (TTM) | $720.20K | |||
| EBITDA (TTM) | -$1.88M | |||
| EBIT (TTM) | -$2.10M | |||
| Net Income (TTM) | -$1.89M | |||
| Net Income Avl. to Common (TTM) | -$1.89M | |||
| Total Revenue Growth (Q YOY) | -50.85% | |||
| Earnings Growth (Q YOY) | -108.98% | |||
| EPS Diluted (TTM) | -$2.45 | |||
| EPS Diluted Growth (Q YOY) | -108.98% | |||
| Balance Sheet | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $5.27M | |||
| Cash Per Share (Q) | $6.84 | |||
| Total Current Assets (Q) | $6.40M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $27.56M | |||
| Current Ratio (Q) | 2.842 | |||
| Book Value Per Share (Q) | $35.72 | |||
| Total Assets (Q) | $51.30M | |||
| Total Current Liabilities (Q) | $2.25M | |||
| Total Debt (Q) | $775.00K | |||
| Total Liabilities (Q) | $23.74M | |||
| Total Common Equity (Q) | $27.56M | |||
| Cash Flow | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | $814.20K | |||
| Cash from Financing (TTM) | -$75.20K | |||
| Net Change in Cash (TTM) | -$1.24M | |||
| Levered Free Cash Flow (TTM) | $2.13M | |||
| Cash from Operations (TTM) | -$1.98M | |||
